[HTML][HTML] Post-allogeneic stem cell transplant FLT3-targeted maintenance therapy: updates and considerations for clinical practice
J Cohen, RT Maziarz - Archives of stem cell and therapy, 2022 - ncbi.nlm.nih.gov
… -targeted therapies, and understanding of the critical nature of MRD status, there is growing
interest in continuation of FLT3-targeted therapies … Guideline recommendations support use …
interest in continuation of FLT3-targeted therapies … Guideline recommendations support use …
Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: Updates and molecular analyses.
BC Carthon, CA Pettaway, LC Pagliaro - Journal of Clinical Oncology, 2010 - ascopubs.org
… Targeted therapy directed at EGFR has met with success in head … patients treated with EGFR
targeted therapy at the University of … of EGFR targeted therapies in AMSCC are warranted. …
targeted therapy at the University of … of EGFR targeted therapies in AMSCC are warranted. …
Novel targeted therapies in chordoma: an update
S Di Maio, S Yip, GA Al Zhrani, FE Alotaibi… - … and clinical risk …, 2015 - Taylor & Francis
… This article provides an update of the current multimodality treatment of … Recommended
articles lists articles that we recommend and is powered by our AI driven recommendation …
articles lists articles that we recommend and is powered by our AI driven recommendation …
Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
MÁ Climent, L León-Mateos, AG Del Alba… - Critical Reviews in …, 2015 - Elsevier
… However, in recent years, several new therapy strategies, such as immunotherapy,
hormonal manipulations, chemotherapy agents and some bone-targeted therapies, have …
hormonal manipulations, chemotherapy agents and some bone-targeted therapies, have …
Systemic therapy for melanoma: ASCO guideline update
R Seth, SS Agarwala, H Messersmith… - Journal of Clinical …, 2023 - ascopubs.org
… The side effects of the recommended immunotherapies and targeted therapies will vary by
patient and by agent. Clinicians should recognize that even grade 1 adverse events, if chronic…
patient and by agent. Clinicians should recognize that even grade 1 adverse events, if chronic…
… of optimal adjuvant chemotherapy regimens for human epidermal growth factor receptor 2 (HER2)–negative and adjuvant targeted therapy for HER2-positive breast …
N Denduluri, MR Somerfield, A Eisen… - Journal of Clinical …, 2016 - ascopubs.org
… an updated, comprehensive guideline on this topic in 2015. … the selection of adjuvant targeted
therapy for HER2-positive … recommendations on chemotherapy and targeted therapy as …
therapy for HER2-positive … recommendations on chemotherapy and targeted therapy as …
Systemic therapy for stage IV non–small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline update
GA Masters, S Temin, CG Azzoli, G Giaccone… - Journal of Clinical …, 2015 - ascopubs.org
… The recommendations were developed by an Update Committee with multidisciplinary …
Nonetheless, there is no absolute preference for chemotherapy versus targeted therapy. …
Nonetheless, there is no absolute preference for chemotherapy versus targeted therapy. …
Targeted therapies in psoriatic arthritis—an update
S Sundanum, C Orr, D Veale - International Journal of Molecular Sciences, 2023 - mdpi.com
… An expanded set of targeted therapies have emerged and have shown efficacy in PsA.
Nevertheless, there is still a substantial subset of patients who experience no response or only a …
Nevertheless, there is still a substantial subset of patients who experience no response or only a …
Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician
… Therapy for CLL has evolved significantly over the past decade with introduction of targeted
therapy for CLL. This has the potential to completely transform how CLL is treated in the …
therapy for CLL. This has the potential to completely transform how CLL is treated in the …
Antineoplastic treatment and renal injury: an update on renal pathology due to cytotoxic and targeted therapies
ML Troxell, JP Higgins, N Kambham - Advances in Anatomic …, 2016 - journals.lww.com
… This review will focus on cytotoxic or targeted chemotherapy-associated renal injury. In
this … Acute kidney injury is rarely reported with targeted therapies such as BRAF inhibitors (…
this … Acute kidney injury is rarely reported with targeted therapies such as BRAF inhibitors (…